Why do some people respond better to GLP-1 drugs? Gut microbiome may hold clues
View as a Web Page
News Medical
 
  Bowel Cancer Bowel Cancer logo  
  The latest bowel cancer news from News Medical  
 Review explores how generative AI could support precision oncology decision-makingReview explores how generative AI could support precision oncology decision-making
 
A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical trials, and synthesizing complex clinical information. The authors emphasize governance, human oversight, and retrieval-based safeguards to ensure these systems are deployed safely in cancer care.
 
 
 Why do some people respond better to GLP-1 drugs? Gut microbiome may hold cluesWhy do some people respond better to GLP-1 drugs? Gut microbiome may hold clues
 
A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment outcomes. The authors conclude that microbiome changes seen during therapy are most likely driven by diet, behavior, and weight loss, although microbial profiling may eventually help predict patient responses.
 
   Experimental therapy eliminates pancreatic precancerous cells in mice studyExperimental therapy eliminates pancreatic precancerous cells in mice study
 
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.
 
   Scientists show gut bacteria can reach the brain in mice and reveal a potential vagus nerve pathwayScientists show gut bacteria can reach the brain in mice and reveal a potential vagus nerve pathway
 
Researchers found that very small numbers of gut bacteria can translocate to the brain in mice, particularly when gut barrier permeability increases due to a Paigen diet. Evidence suggests the vagus nerve may serve as a partial route for this gut-to-brain microbial movement.
 
 Study reveals microbiome role in protecting the colon from tissue injury
 
Study reveals microbiome role in protecting the colon from tissue injuryThe gut microbiome-the trillions of bacteria and other microbes that inhabit the gastrointestinal tract-drives a process vital for protecting the colon against tissue injury, according to the findings of a study co-led by Cedars-Sinai Health Sciences University investigators.
 
 
 3D organoid culture and AI-enabled decision-making
 
3D organoid culture and AI-enabled decision-makingLearn how the CellXpress.ai uses AI decision making for enhanced 3D organoid culture.
 
 
 Specific gut bacterium Roseburia linked to stronger muscles and better fitness
 
Scientists from the University of Almería and the University of Granada, together with researchers from Leiden University Medical Center (LUMC, Netherlands), have identified an intestinal bacterium of the genus Roseburia associated with stronger muscles and improved physical condition.
 
 
 Specific gut microbe may boost muscle strength and performance
 
A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal Gut.
 
 
 Researchers identify cellular drivers of gut scarring in Crohn’s disease
 
As inflamed regions of the gut form scar tissue, the space within the gut lumen becomes smaller and more restricted, leading to symptoms of gut obstruction.
 
 
 Gut microbiome-produced nicotinic acid protects colon tissue from injury
 
The gut microbiome-the trillions of bacteria and other microbes that inhabit the gastrointestinal tract-drives a process vital for protecting the colon against tissue injury, according to the findings of a study co-led by Cedars-Sinai Health Sciences University investigators.
 
 
 New AI system reduces pathologist workload while maintaining diagnostic accuracy
 
Artificial intelligence could make cancer diagnosis safer and fairer by learning when to defer to human pathologists without overloading them, according to researchers from the University of Surrey and Monash University.
 
 
 Protein MIIP suppresses colorectal cancer by regulating immune cell signaling
 
Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and limited responses to immunotherapy in most patients.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026